Drug Shortage Report for JAMP-METHOTREXATE
Report ID | 4836 |
Drug Identification Number | 02419173 |
Brand name | JAMP-METHOTREXATE |
Common or Proper name | Methotrexate Solution |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS |
Packaging size | 5x2 |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-09-15 |
Estimated end date | |
Actual end date | 2020-09-04 |
Shortage status | Resolved |
Updated date | 2020-10-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2020-10-09 | French | Compare |
v14 | 2020-10-09 | English | Compare |
v13 | 2020-02-18 | French | Compare |
v12 | 2020-02-18 | English | Compare |
v11 | 2019-03-01 | French | Compare |
v10 | 2019-03-01 | English | Compare |
v9 | 2018-12-19 | French | Compare |
v8 | 2018-12-19 | English | Compare |
v7 | 2018-10-15 | French | Compare |
v6 | 2018-10-15 | English | Compare |
v5 | 2017-09-25 | French | Compare |
v4 | 2017-09-25 | English | Compare |
v3 | 2017-09-25 | English | Compare |
v2 | 2017-03-30 | French | Compare |
v1 | 2017-03-30 | English | Compare |
Showing 1 to 15 of 15